Skip to main content

Solid Tumor Program News

Every person on your child’s team has the same goal: to give your child the best possible care. We provide medical care, emotional support and much more.

Existing patients or family members
New patients, referrals and second opinions

Q&A with Joshua Eisenberg, MD

Aug 9, 2022

Get to know Dr. Joshua Eisenberg, our newest attending physician in the Division of Gastroenterology, Hepatology and Nutrition.

FDA Approves Drug for Rare Cancer

Jul 25, 2022

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

Jump back to top